Document Detail


MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
MedLine Citation:
PMID:  23050614     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: To investigate the clinical significance of micro-ribonucleic acid-155 in clear cell renal cell carcinoma, in particular focusing on the association of expression levels of micro-ribonucleic acid-155 with clinicopathological factors, cancer-specific survival and therapeutic outcomes in clear cell renal cell carcinoma patients. METHODS: Quantitative reverse transcription polymerase chain reaction of micro-ribonucleic acid-155 was carried out on 137 clear cell renal cell carcinoma cases, containing 77 matched pairs of clear cell renal cell carcinoma and normal adjacent kidney tissues from the same patients. RESULTS: Significant overexpression of micro-ribonucleic acid-155 was found in clear cell renal cell carcinoma compared with normal kidney tissue. Expression of micro-ribonucleic acid-155 was not associated with prognosis in all stage groups. However, in 43 patients with stage III and IV clear cell renal cell carcinoma, low expression levels of micro-ribonucleic acid-155 correlated with a poor prognosis. Regarding cancer-free survival of 26 patients with stage III and IV clear cell renal cell carcinoma who received curative resection and cancer-specific survival of 31 patients who received postoperative therapy with interferon-α after radical nephrectomy, low expression levels of micro-ribonucleic acid-155 correlated with poor clinical outcomes in these two groups. CONCLUSIONS: Low expression of micro-ribonucleic acid-155 represents a valuable marker of poor clinical outcomes in patients with stage III and IV clear cell renal cell carcinoma.
Authors:
Shunsuke Shinmei; Naoya Sakamoto; Keisuke Goto; Kazuhiro Sentani; Katsuhiro Anami; Tetsutaro Hayashi; Jun Teishima; Akio Matsubara; Naohide Oue; Yasuhiko Kitadai; Wataru Yasui
Related Documents :
23879724 - High-throughput screening for identification of inhibitors of epcam-dependent growth of...
23904264 - Physiological role of the interaction between carmil1 and capping protein.
23887884 - Physiological tests for yeast brewery cells immobilized on modified chamotte carrier.
24503564 - Antioxidant enzymes regulate reactive oxygen species during pod elongation in pisum sat...
22358604 - A new apparatus for studying the effect of hydrostatic pressure on cells in culture : a...
20674434 - Metabolomic analysis of normal and sickle cell erythrocytes.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-10
Journal Detail:
Title:  International journal of urology : official journal of the Japanese Urological Association     Volume:  -     ISSN:  1442-2042     ISO Abbreviation:  Int. J. Urol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9440237     Medline TA:  Int J Urol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Japanese Urological Association.
Affiliation:
Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Delphi consensus study among patients and clinicians in the Netherlands on the procedure of inform...
Next Document:  Reflections on strategic nurse leadership.